Morinaga Human-Residential Bifidobacteria (HRB) Probiotics

1. Bifidobacterium longum BB536: Multifunctional Human Bifidobacteria Probiotic Flagship probiotics of Morinaga Milk. It is a strain of bifidobacteria naturally reside in human intestines. It has been the superior HRB probiotic strain that provides a consistent beneficial effect in the improvement of intestinal health, maintenance of intestinal microflora balance, regulation of immune response, anti-allergy, and protection against microbial infections. Key clinical and mechanistic studies reveal that BB536 acts in concert with the gut microbiota to drive a fine-tuned intestinal and immune balance. Due to its robust safety, efficacy and stability profile, BB536 has gained wide recognition in the marketplace. Morinaga provides BB536 for not only use in dietary supplements and infant formulas but also as cultures used in yoghurt and yoghurt drinks. 2. Bifidobacterium infantis M-63: Superior Potential for Infant Use Unique among gut bacteria in its immense capacity to utilize human milk oligosaccharide (HMOs), the component that is highly abundant in human breast milk. HMOs offer no direct nutritive value for infants, but they function in shaping a better infant gut microbiota with life-long impacts. M-63 possesses superior potential to colonize and adapt to the intestinal environment of humans, especially infants. 3. Bifidobacterium breve M-16V: Ideal Probiotic for Infant Health One of the predominant species present in the infant gut and is widely recognized for its beneficial roles in maintaining infant health. It has emerged as one of the best studied clinically effective probiotic strains that exert positive effects, particularly in infants, to support healthy growth and promote well-being. 4. Bifidobacterium breve B-3: Weight Management Probiotics An unique probiotic strain developed by focusing on the relationship between gut microbiota and metabolic syndrome. B-3 possesses an effect in maintaining healthy body weight and ultimately improving lifestyle.